Kura Oncology Inc. share price logo

Kura Oncology Inc.

NASDAQ: KURA

Small Cap

$9.93

+0.36

(+3.76%)

as on

Kura Oncology Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $9.55
    $9.98
    downward going graph

    3.83%

    Downside

    0.50%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.45
    $12.49
    downward going graph

    45.12%

    Downside

    25.78%

    Upside

    downward going graph

Kura Oncology Inc. share price movements today

Previous Close
$9.57
Open
$9.77
Volume
960.4K
Day's Low - High
$9.55 - $9.98
52 Week Low - High
$5.45 - $12.49

Kura Oncology Inc. Historical Returns

1 Month Return
+ 10.83 %
3 Month Return
+ 17.79 %
1 Year Return
+ 63.86 %
3 Year Return
-7.71 %
5 Year Return
-54.82 %

Kura Oncology Inc. Stock Fundamentals & Key Indicators

Check Kura Oncology Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$861.1M

EPS (TTM)

-3.5413

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-316.6M

Revenue (TTM)

71.6M

Profit Margin

0.00%

Return On Equity TTM

-124.74%

Kura Oncology Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kura Oncology Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Kura Oncology Inc. image
Kura Oncology Inc.
BUY$861.1M-54.82%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Kura Oncology Inc. Stock including INR - Dollar returns

The Kura Oncology Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kura Oncology Inc. investment value today

Current value as on today

₹1,78,491

Returns

₹78,491

(+78.49%)

Returns from Kura Oncology Inc. Stock

₹63,861 (+63.86%)

Dollar Impact

₹14,630 (+14.63%)

Analyst Recommendation on Kura Oncology Inc. Stock

Based on 20 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Kura Oncology Inc.. Average target price of $31.17

Kura Oncology Inc. Share Price Target

Get share price movements and forecasts by analysts on Kura Oncology Inc..

What analysts predicted

68.14%UPSIDE

Target Price

$31.17

Current Price

$9.93

Analyzed by

20 Analysts

Target

$31.17

Kura Oncology Inc. target price $31.17, a slight upside of 68.14% compared to current price of $9.93. According to 20 analysts rating.

Indian Investors' Interest in Kura Oncology Inc. Stock

Search interest for Kura Oncology Inc. Stock has increased by 127% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:127% versus previous 30 day period

Kura Oncology Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1
-
-
-
53
14
15
20
17
18
Gross Profit
0
0
0
0
53
14
15
17
17
17
Operating Income
-46
-54
-56
-59
-22
-64
-72
-79
-86
-78
EBITDA
-42
-48
-50
-53
-16
-64
-65
-73
-80
-72
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-42
-49
-50
-54
-17
-57
-66
-74
-80
-73
Income Tax Expense
2
0
-
-
2
0
-
-
0
0
Net Income
-42
-49
-50
-54
-19
-57
-66
-74
-80
-73
Net Profit Margin
-3368.98%
0.00%
0.00%
0.00%
-35.66%
-407.07%
-432.51%
-357.19%
-467.23%
-401.49%

Kura Oncology Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
53
67
Gross Profit
0
0
0
-
0
0
0
0
53
67
Operating Income
-28
-36
-62
-67
-91
-131
-139
-165
-193
-303
EBITDA
-28
-36
-62
-67
-88
-129
-134
-150
-169
-275
Interest Expense
0
0
0
0
0
0
0
1
1
1
Depreciation
-
0
0
0
0
0
0
0
0
1
Income Before Tax
-27
-35
-60
-63
-89
-130
-135
-152
-171
-278
Income Tax Expense
0
0
3
-4
0
0
0
-
2
0
Net Income
-27
-35
-60
-63
-89
-130
-135
-152
-173
-278
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-322.89%
-412.95%

Kura Oncology Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-49
-50
-54
-19
-57
-66
-74
-80
-73
Operating Cash Flow
-48
-42
-43
269
-71
-28
-80
117
-85
Investing Cash Flow
-95
43
45
-94
-101
58
93
-64
-24
Financing Cash Flow
148
3
2
0
0
0
-
1
0
Change in Cash
4
3
4
174
-173
30
13
53
-110

Kura Oncology Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-35
-60
-63
-89
-130
-135
-152
-173
-278
Operating Cash Flow
-28
-48
-54
-69
-104
-110
-124
134
-64
Investing Cash Flow
-23
-79
-46
-99
-126
32
15
-101
-13
Financing Cash Flow
53
132
111
469
-3
38
94
154
1
Change in Cash
1
4
10
299
-234
-38
-14
187
-75

Global Institutional Holdings in Kura Oncology Inc.

Funds
Holdings
BlackRock Inc
10.86%
Suvretta Capital Management, LLC
9.66%
Goldman Sachs Group Inc
1.08%
Bvf Inc
9.51%
State Street Corp
5.08%
See all

Insights on Kura Oncology Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KURA stock has moved up by 9.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, KURA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, KURA has outperformed top 5 stocks with highest market-cap in its industry

About Kura Oncology Inc.

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
OrganisationKura Oncology Inc.
Headquarters4930 Directors Place, San Diego, CA, United States, 92121
IndustryBiotechnology
CEODr. Troy Edward Wilson J.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Kura Oncology Inc.

Name

Title

Mr. Brian T. Powl M.B.A., M.S.

Chief Commercial Officer

Mr. Thomas Doyle

Senior Vice President of Finance & Accounting

Dr. Roger Bakale Ph.D.

Senior Vice President of Manufacturing & Supply Chain

Dr. Troy Edward Wilson J.D., Ph.D.

Chairman, CEO & President

Ms. Kathleen Ford

Chief Operating Officer

Dr. Francis J. Burrows Ph.D.

Chief Scientific Officer

Mr. Greg Mann

Senior Vice President of Investor Relations & Corporate Affairs

Ms. Teresa Brophy Bair Esq., J.D.

Chief Legal Officer & Corporate Secretary

Dr. Mollie Leoni M.D.

Chief Medical Officer

Mr. Samir Vattompadam M.S.

Senior Vice President of Global Program Leadership

FAQs

What is Kura Oncology Inc. share price today?

Kura Oncology Inc. share price today is $9.93 as on at the close of the market. Kura Oncology Inc. share today touched a day high of $9.98 and a low of $9.55.

What is the 52 week high and 52 week low for Kura Oncology Inc. share?

Kura Oncology Inc. share touched a 52 week high of $12.49 on and a 52 week low of $5.45 on . Kura Oncology Inc. stock price today i.e. is closed at $9.93,which is 20.50% down from its 52 week high and 82.20% up from its 52 week low.

What is Kura Oncology Inc.'s market capitalisation today?

Kura Oncology Inc. market capitalisation is $0.00T as on .

How to invest in Kura Oncology Inc. Stock (KURA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kura Oncology Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kura Oncology Inc. Shares that will get you 0.1511 shares as per Kura Oncology Inc. share price of $9.93 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Kura Oncology Inc. Stock (KURA) from India?

Indian investors can start investing in Kura Oncology Inc. (KURA) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Kura Oncology Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Kura Oncology Inc. share’s latest price of $9.93 as on June 19, 2026 at 8:45 am IST, you will get 1.0070 shares of Kura Oncology Inc.. Learn more about fractional shares .

What are the returns that Kura Oncology Inc. has given to Indian investors in the last 5 years?

Kura Oncology Inc. stock has given -54.82% share price returns and 27.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?